Infarction  >>  Tekturna (aliskiren)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tekturna (aliskiren) / PDL
NCT00414609 / 2006-001704-37: Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE)

Completed
3
820
US, Canada, Europe, RoW
Aliskiren, Tekturna®, placebo
Novartis
Myocardial Infarction
09/09
07/11

Download Options